Navigation Links
Microfluidics International Corporation Announces Third Quarter 2009 Financial Results
Date:11/2/2009

ime. Participants are invited to attend the call by visiting www.microfluidicscorp.com or by dialing 866-356-4281 (within the United States) or 617-597-5395 (outside the United States). The passcode for participants is 96732749.

A replay will be available approximately two hours after the live call through November 9, 2009. To access the replay, dial 888-286-8010 (within the United States) or 617-801-6888 (outside the United States). The passcode for participants is 69691770. A replay will also be posted on the Company's website approximately two hours after the live call and will be available for a period of 30 days.

About Microfluidics International Corporation

Microfluidics International Corporation designs, manufactures and distributes patented and proprietary high performance Microfluidizer® materials processing and formulation equipment to the biotechnology, pharmaceutical, chemical, cosmetics and inkjet ink industries. The Company applies its 20 plus years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid particles available and has provided manufacturing systems for nanoparticle products for more than 15 years.

Microfluidics is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to the Company's equipment customers.

Non-GAAP Financial Measures:

In addition to the results reported in accordance with generally accepted accounting standards (GAAP) within this release, the Company may reference certain information that is considered a non-GAAP financial measure, including EBITDA, which is define
'/>"/>

SOURCE Microfluidics International Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Microfluidics International Corporation to Report Third Quarter 2009 Financial Results on November 2, 2009
2. Microfluidics International Corporation Announces Second Quarter 2009 Financial Results
3. Microfluidics International Corporation to Report Second Quarter 2009 Financial Results on August 11, 2009
4. Particle Sciences and Microfluidics Collaborate to Share Formulation and Nanotechnology Expertise for Pharmaceutical Drug Product Development, Analysis and Commercialization
5. Nanopoint Applies CE Mark to Its cellTRAY(R) Imaging and Microfluidics Systems
6. Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries
7. GEN Reports on Growing Reliance on Microfluidics Technology
8. RainDance Technologies to Present Sequence Enrichment Using Droplet-Based Microfluidics Workshop at ASHG 2008
9. eBioscience Acquires Bender MedSystems; Business Combination Adds Cutting-Edge Product Lines and Expands International Operations
10. Qteros Employees Planting Special Trees in Celebration of International Day of Climate Action, October 24, 2009
11. China Medical Technologies to Exhibit its Products at China International Medical Equipment Fair in Chengdu, China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)... Shire plc (LSE: SHP, Nas...cal company, today announced a voluntary recall of...lot of the Attention-Deficit/Hyperactivity Disorde...his action because some Daytrana patches do not me...er removal specification, and as a result, patient...
(Date:12/3/2009)...c. 3 Caliper Life Scienc...ools and services for drug discovery and life scie...oftware for IVIS® in vivo imaging systems. Li...er IVIS systems currently installed in laboratorie...ectral unmixing tools to enhance fluorescent sensi...
(Date:12/2/2009)...c. 2 Spectrum Blue Steel is emergi...anies on the planet. Through the efforts of True G...t and Recycling Specialist Leroy Johnston, who has... stated that Spectrum Blue Steel is light years ah...acular earnings because of the bi products recover...
(Date:12/2/2009)... Reportlinker.com announces that a...talogue: ,, Drug Discovery Technologies - A Gl...,, http://www.reportlinker.com/p0164246/Drug-D...Trends--Opportunities.html ,, Drug discovery h... pharmaceutical company,s business strategy. There...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Caliper Life Sciences Launches Living Image(R) 4.0 Software 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9
... is Cepheid,s Second FDA Cleared Diagnostic Test i...n Twenty-Four Hours Over Conventional ...t. 1 Cepheid (Nasdaq:,CPHD) today announced it ha...inistration (FDA) to market its Xpert(TM) MRSA/SA ...rt(R) System, for the detection of,Methicillin-res...
... October 1 , - "Expert Consult" Title Regularly I... Always Current, Elsevier, the leading publisher ... publication of the 40th edition of the most famou...y: The Anatomical Basis of Clinical,Practice ( htt...0443066849 ),in September 2008., In celebration o...
...if., Oct. 1 Lumiphore, Inc., a,biotechnology lead...nt,metal-lanthanide technology for use in high-val...xclusive agreement with Biophor Diagnostics, Inc.,...ts in diagnostic tests,for drugs of abuse., Under...usive worldwide,rights to Lumi4(TM) technology in ...
Other Biology Technology:Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 2Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 3Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 4Cepheid Receives FDA Clearance for First On-Demand Diagnostic Test for Life-Threatening MRSA and Staphylococcus aureus From Patient Positive Blood Cultures 5New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 2New 40th Edition of Gray's Anatomy Celebrates 150 Years as the World's Preeminent Anatomical Reference 3Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board 2
(Date:12/2/2009)...ntain forest,s woodland herb population has shown ...ories recover from logging, according to Purdue Un...rtions of the forest nearly 80 years ago, the dist...t floor was similar to that of undisturbed areas. ...orestry and natural resources, said that contrasts...
(Date:12/2/2009)...nter researchers have figured out how stem cells i...able to resist radiation therapy. And using a drug...cancer stem cells, they were able to kill many mor...riment. , The work builds off earlier research ...ects of radiation much better than other cancer ce...
(Date:12/2/2009)...roduct called moist snuff placed between lip and ...obacco industry to change manufacturing practices ...udy is published online in ACS, monthly journal C...his category of tobacco products contains surprisi...ng substances. Called polycyclic aromatic hydrocar...
Breaking Biology News(10 mins):Study finds logging effects vary based on a forest's history, climate 2Discovery makes brain tumor cells more responsive to radiation 2INV102 Asthma Product Discussed at the European Respiratory Society 14206 1INV102 Asthma Product Discussed at the European Respiratory Society 14206 2ESMO recognizes centers of excellence in palliative care for cancer patients 57956 1ESMO recognizes centers of excellence in palliative care for cancer patients 57956 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 1NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 2NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 3NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 4NKTR 102 Shows Encouraging Anti Tumor Activity in Ovarian Cancer in Phase 1 and Preclinical Data Presented at the ECCO 15 and 34th ESMO Multidisciplin 5029 5
..., Nitrogen pollution from agriculture and fossil ... in the UK. A new European study is starting to sh... current policies to protect ecosystems may need a...in 2004, her findings were so significant they wer...elected as contributing to one of the top ten scie...
..., Athens, Ga. For the estimated millions of AIDS...oping resistance to currently available medicines,... may offer a new treatment option by targeting a p... responsible for the devastating disease. , Appr...ectious viral disease known as HIV-AIDS. Although ...
..., WALNUT CREEK, -The genome analysis of a tiny gr...uniquely associated with carbon dioxide capture an...es revealed in the study are those that encode the...le that houses the photosynthetic apparatus, the c...ght to chemical energy. The genome also provides ...
Other Biology News:Nitrogen -- the silent species eliminator 2Nitrogen -- the silent species eliminator 3New class of drug offers hope to treatment-resistant AIDS patients 2New class of drug offers hope to treatment-resistant AIDS patients 3Green alga genome project catalogs carbon capture machinery 2Green alga genome project catalogs carbon capture machinery 3
Mouse Anti-Keap1 Monoclonal Antibody, Unconjugated, Clone 333116 from R&D Systems
Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON
Normal Guinea Pig Serum from Equitech-Bio
ELF 97 Cytological Labeling Kit *with streptavidin alkaline phosphatase conjugate* *50 assays* from Molecular Probes (Invitrogen)
Biology Products: